pharma

YOU MIGHT BE INTERESTED IN

Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020
The pharmaceutical anti-counterfeiting market has been generating increasing revenues in recent years, with strong growth to come, as our new report explains and quantifies. Counterfeit drugs cost the pharmaceutical industry billions of dollars annually in lost revenues, with risk to patients and brands. Drug counterfeiting is increasing worldwide, with greater sophistication by counterfeiters and increased online drug purchasing. The rising prevalence of counterfeiting yields significant commercial opportunities for companies offering anti-counterfeiting solutions, as well as for their clients. Companies worldwide are investing in technologies to fight this threat to pharma stakeholders.
...more details

CONFERENCE

...see all

Anti-Counterfeiting Americas

Best practices for protecting the pharmaceutical supply chain against counterfeiting and fraud

8th - 9th November 2010, Boston, USA

Download brochure Book now

Background Info
Day 1
Day 2
Partners
Past Papers
Speakers

Associate Sponsors

Media Partners

Background Info

Key Speakers
• Scott LaGanga, Executive Director, Partnership for Safe Medicines
• Lorne M Lipkus, Partner, Kestenberg Siegal Lipkus LLP
• Robert Celeste, Director, Healthcare, GS1 US
• Andres Diaz Cote, President, Figurazione
• Steve Wood, President & CEO, Covectra
• Sharon Flank, CEO, InfraTrac
• Philip Payne, Investigative Partner, RSSL
• Jen Marcum, CEO, Sentry BioPharma Services
• Jim Williams, Founder & Chief Scientist, Polyonics

Increasing efforts are being made to protect the national supply chain for medicines distribution. In the US, the pharmaceutical supply chain involves the daily delivery of approximately 13 million prescription products to pharmacies, hospitals, clinics and other healthcare provider locations (Source: Urch Publishing, July 2009).

Visiongain's Anti-Counterfeiting Americas conference will provide valuable insights, into the latest issues and track and trace packaging technologies shaping the fields of security and supply chain management, with leading experts presenting the best-practices on tackling pharmaceutical counterfeiting and fraud, improving the integrity of distribution channels and relationships between key parties.

By attending the Anti-Counterfeiting Americas conference delegates will gain a comprehensive understanding of this rapidly changing sector, from the complex structure of the supply chain, to the growth in mail order and online pharmacies. The potential for investment in the pharmaceutical logistics market remains high. The FDA has put additional focus on "corporate responsibility" for supply-chain management, and increased vigilance and action is needed due to the rise of counterfeit drugs in the global supply chain. Anti-counterfeiting initiatives discussed include the use of technology-based measures, repackaging, consumer education, and increased collaboration with domestic and international law enforcement agencies.

By attending this conference you will:
• Measure the impact of counterfeit drugs by using a patient centric approach
• Understand the development process necessary to ensure an effective security strategy
• Improve inventory control
• Hear changes in the US FDA and European policies
• Develop global standards to increase patient safety and elevate supply chain integrity
• Learn about leveraging supplier audits throughout a global organization
• Understand the challenges of the global traceability and serialization regulatory environment
• Utilize auto-ID advancements in packaging technologies
• Hear the latest strategies for defending your brand and pursuing offenders
• Develop working relationships with US law enforcement authorities
• Balance the need for tamper-proof packaging with streamlining your supply chain
• Evaluate current methods for the detection of counterfeit medicines
• Be part of a unique networking opportunity

Target Audience:
• Pharmaceutical manufacturing and distributing companies
• Drug wholesalers
• Public health and regulatory bodies
• Legal firms
• Customs and border agencies
• Pharmaceutical packaging and labelling companies
• Anti-counterfeiting technology and service suppliers
• Pharmaceutical specialist couriers
• Anti-counterfeiting organizations
• Contract manufacturing organizations (CMOs)
• Retail pharmacy chains
• Non-governmental healthcare organizations and Academia

Who should attend:

Chief Security Officers, VPs, directors, heads, managers and specialists of:
• Supply chain/ Supply Chain Security/ Supply Chain Systems/ Global Supply Chain
• Anti-counterfeit Projects / Anti-counterfeiting Operations
• Distribution/ Logistics
• Security/ Global Security
• Packaging & Labelling
• Brand Protection
• Legal Counsel
• Regulatory Affairs/ Intellectual Property
• Quality Assurance/ Quality Control
• Compliance
• Information systems

Day 1

Day 1, Monday 8th November 2010

09:00 Registration and refreshments

09:30 Opening address from the chair

Lorne M Lipkus
Partner
Kestenberg Siegal Lipkus LLP

09:40 The business value of product serialization within the pharmaceutical supply chain
Across the U.S. pharmaceutical supply chain, organizations are aligning themselves to enable more effective product serialization and increased visibility using new standards. With widespread serialization comes tremendous opportunity for pharmaceutical manufactures and their trading partners to leverage new standards for increased efficiency and greater ROI. In this session, the GS1 Healthcare US organization, the US implementation arm of the leading standards-setting body for product identification, illustrates the business value of serialization and pedigree/visibility information.
• GS1 EPCIS standard as a pathway to significant potential business value
• The status of adoption of GLN and GTIN in pharma
• The industry status for using serial data to match product
• How serialization can provide enormous visibility into the supply chain
• Update on the 2015 readiness program (preparing for serialization and pedigree within the US)

Robert Celeste
Director, Healthcare
GS1 US

10:20 Forging strategic partnerships to elevate product integrity
• Industry trends
• Developing and applying a risk management process
• Assessing qualifications
• Transitioning a qualified vendor into a strategic partner
• Case study

Jen Marcum
CEO
Sentry BioPharma Services

11:00 Morning refreshments

11:20 Securing pharmaceuticals against counterfeiting: Assessing latest protection technologies
• Latest developments in anti-counterfeiting technologies
• Packaged-bases vs on-product solutions
• Designing a comprehensive anti-counterfeiting strategy

Frank Schurgers
Managing Director
Integris

12:00 Counterfeiting in developing countries: The use of mixed technology
• External control in massive consume products
• The ‘umbrella brand’ concept: The perfect attack
• Internal control in massive consumer products
• The colombia case
• Results and real benefits

Andres Diaz Cote
President
Figurazione

12:40 Networking lunch

13:40 Implementing a cost effective anti-counterfeiting enforcement program
• Tips, techniques and best practices for implementing and maintaining an anti-counterfeiting enforcement system
• Taking the necessary steps: auditing, registering and tracking your intellectual property rights
• Setting an enforcement policy specifically designed for your company
• Tracking and brand protection tools and technology

Lorne M Lipkus
Partner
Kestenberg Siegal Lipkus LLP

14:20 Track and Trace at the WIP manufacturing level
• Overview for analyzing tradeoffs between brand protection technologies
• Why is information regarding authentication of products and their movement critical?
• “Pre-adaption” of pharmaceutical manufacturers to incorporate brand authentication as an integral part of their existing operations

Jim Williams
Founder & Chief Scientist
Polyonics

15:00 Afternoon refreshments

15:20 Recent advances in holographic protection for pharmaceuticals
• Simple Track&Trace by holographic RFID solutions
• Covert protection by holographic microparticles
• Simple authentication using achromatic holograms

Jon Powel
Commercial Director
Optaglio

15:40 Supporting safe medicines strategies in developing countries
• Which developed countries are the most susceptible destination markets for counterfeit drugs?
• Assessing the scale and economic cost of counterfeiting
• Discuss the role of drug regulations and law enforcement
• Cooperation with national & international agencies

Tom Woods
President
Woods International

16:20 Closing remarks from the chair

16:30 Networking drinks
Take your discussions further and build new relationships in a relaxed and informal setting

Day 2

Day 2, Tuesday 9th November 2010

09:00 Registration and refreshments

09:30 Opening address from the chair

Jen Marcum
CEO
Sentry BioPharma Services

09:40 Cost-effective anti-counterfeiting solutions for the second tier
• Repackaging and counterfeiting
• Technologies
• Evaluate packaging-based and product-based anti-counterfeiting measures by cost, complexity, and effectiveness for second tier products

Sharon Flank
CEO
InfraTrac

10:20 Protecting medicines from diversion and counterfeiting
• A multi-layered approach for brand protection
• Specialty distribution as a tool for combating diversion
• Using smartphones and mobile phones in brand integrity and loyalty programs

Steve Wood
President & CEO
Covectra

11:00 Morning refreshments

11:20 Illegal internet pharmacies: A framework for coordinated action and cooperation
• Illegal internet pharmacies: Extent of the problem
• Action against illegal internet pharmacies: What has been done?
• What remains to be done: The need for additional action

Charlie Cichon
Executive Director
The National Association of Drug Diversion Investigators (NADDI)

12:00 Item Level Authentication and Visibility System
Implementing an item-level authentication system combined with supply chain visibility and track/ trace capabilities.
• Providing authentication, utilizing nonClonableID™ fingerprint technology, locally via web-based server
• Authentication vs. visibility
• Lessons learned from other industries

Liz Churchill
Director, Marketing and Business Development
Bilcare Technologies

12:20 Networking lunch

13:20 Detecting pharmaceutical counterfeiting
• Stages of investigation
• Investigation and detection of contamination in pharmaceutical products
• QC and GMP techniques

Philip Payne
Investigative Partner
RSSL

14:00 Case study: Utilizing forensic analysis in support of counterfeit investigations
The presentation will look at various strategies to utilize forensic evidence for carrying out counterfeit investigations

Vaughn Volpi
President
PICA

14:40 Afternoon refreshments

15:00 The global impact of fake medicine
• Overview of the counterfeit drugs: Some examples
• How fake medicines harm patients and public
• Building a Coalition: A call to action

Scott LaGanga
Executive Director
Partnership for Safe Medicines

15:40 Protecting profits and patient safety through implementing new technologies
• Preventative technologies
• Authentication technologies
• Track & Trace technologies

16:20 Chair’s closing remarks

16:30 End of conference

Partners

Associate Sponsors:

Optaglio
Optaglio focuses on research, development and production of high-tech optical security devices for protection of banknotes, IDs, documents and branded products. Our philosophy is to provide high-end security solutions for protection of goods and documents for everyday life. Solutions by Optaglio are based on long term experience, good understanding of our clients' needs and individualized and innovative approach. Optaglio have gained trust of governments as well as private companies worldwide and supplies in more than 50 countries. For further information, please visit www.optaglio.cz

OYSTAR Manesty
For further information, please visit www.oystar.manesty.com

Bilcare Technologies
Bilcare Technologies is a technology leader focused on creating next-generation anti-counterfeiting, security, supply chain integrity and brand protection solutions for a broad range of industry sectors. With breakthrough development in micro and nanotechnology, Bilcare Technologies has developed a first-of-its-kind technology - nonClonableID™. The solution enables individual products to be authenticated as they move through the supply chain to the end consumer. With its affordability, security and ease of use, nonClonableID is a potent tool for the global economy in its fight against counterfeiting.
Headquartered in Pune, India, Bilcare Technologies is a business unit of Bilcare Ltd., an innovation-led solutions provider that partners with the global pharmaceutical and healthcare industry to improve patient healthcare outcomes. For further information, please visit www.bilcaretech.com

Media Partners:

PharmiWeb.com
PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com

BIOTECHNOLOGY EUROPE
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com

Future Pharmaceuticals
Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide. For further information, please visit www.futurepharmaus.com

InPharm
InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and Pharmafocus. For further information please visit: www.In-Pharm.com

Pharma Connections Worldwide
Pharma Connections Worldwide® is the leading professional business networking website focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to provide a conduit for delivery of premiere content coupled with the right clientele in order to facilitate business development opportunities among industry professionals responsible for making key decisions in a global marketplace. For further information please visit www.pharmaconnections.com

The Partnership for Safe Medicines
The Partnership for Safe Medicines is a coalition of more than 50 patient, physician, pharmacist, university, industry and other professional organizations around the world committed to the safety of prescription drugs and protecting consumers against unapproved, counterfeit, substandard, mishandled or otherwise unsafe medicines. For more information, please visit www.SafeMedicines.org

Pharmaceutical anti-counterfeiting news from SecuringPharma.com.
SecuringPharma.com is a free-to-access information service that covers the issues surrounding counterfeit medicines and supply chain security in the pharmaceutical industry. Our aim is to provide practical advice and market intelligence to help drugmakers keep up-to-date with developments in the field and define their own strategies to safeguard the supply chain, from raw materials right through to the patient. For further information, please visit www.securingpharma.com

Enquiries

If you would like more information on the range of sponsorship or exhibition possibilities for visiongain's Pharmaceutical Anti-counterfeiting Americas Conference, please contact:
Ronald Reyes Magali: +44 (0)20 7549 9934
ronald.magali@visiongainglobal.com
John Changkarn: +44 207 549 9968
john.changkarn@visiongainglobal.com

Past Papers

Speaker presentations are free to delegates. If you are unable to attend the event, the presentations are published two weeks after the event and are available to purchase.

Buy Now

Speakers

Speaker bios:

Liz Churchill

Head of Marketing and Business Development

Bilcare Technologies

Liz has many years experience in delivering solutions to improve visibility and security in supply chains, from production to the end user. She is heading Marketing and Business Development for Bilcare Technologies, a company that has developed nonClonableID™, a first-of-its-kind micro/nanotechnology, enabling individual products to be authenticated as they move through the supply chain to the end consumer.